© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 4.59% of BBLG shares are held by financial institutions. WARBERG ASSET MANAGEMENT LLC is the top corporate investor, holding 0 shares valued at -. A 0% stake in Bone Biologics Corporation is owned by the company. UBS GROUP AG owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the BBLG insiders holding of 5.21% of the stake in company, HANKEY DON, Chairman of the Board, holds the largest shares of 28.56M. HANKEY BRET, director, is the second largest BBLG insider with ownership of 28.12M shares. MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC., 10 percent owner, stands third with possession of 11.64M shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own BBLG shares is 8, representing 4.59% of the company's common stock.
WARBERG ASSET MANAGEMENT LLC, in the last quarter, reduced its stake in BBLG by -100% restricting it's holding to 0 shares of worth nearly -. UBS GROUP AG also lessened -100% of the BBLG shares from its portfolio, reducing its holding to 0 shares of worth -. MFA WEALTH ADVISORS, LLC also shunned BBLG shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, N/A increased its stake in BBLG by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of BBLG to its portfolio, raising its holding to - shares of worth -. N/A also increased its BBLG shares holding by N/A which brought its holding to - shares worth -.
The insider with the most stakes in BBLG is Hankey Don , Chairman of the Board at the company. Additionally, BBLG stock is highly held by director Hankey Bret and 10 percent owner MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. among others.
Company executives, directors, and other insiders own 5.21% percent of Bone Biologics Corporation's stock. Within the last six months, there have been 0 transaction(s) in which BBLG insiders have sold stock, totaling 0 shares. Insiders that have sold shares include SOO B CHIA, WU BENJAMIN, and AFH HOLDING & ADVISORY, LLC.
There have been 0 transaction(s) during the past 6-months in which Bone Biologics Corporation insiders have bought stock, totalling 0 shares
Around 0 Bone Biologics Corporation shares are held by insiders, which represents about 5.21% of BBLG stock.
BBLG Chairman of the Board, Hankey Don holds the largest portfolio of the company's shares. BBLG shares owned by Hankey total nearly 28.56 million.
WARBERG ASSET MANAGEMENT LLC is the largest institutional owner in BBLG which holds 0 shares worth - or 0% of the total BBLG shares outstanding followed by UBS GROUP AG with ownership of 0 shares representing 0% of the BBLG ownership. MFA WEALTH ADVISORS, LLC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the BBLG is concerned, it is a stock which is not optionable.
Number of BBLG shares short is 72.06K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 2.46M shares of BBLG are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, BBLG has 1.72M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for BBLG is 0.18.